Global epidemiological trend of Klebsiella pneumoniae ST340: emergence of subclade KL15 co-producing K pneumoniae carbapenemase-2 and New Delhi metallo-β-lactamase-7 in the Americas
The Lancet Microbe · 2025-02 · 6 (2) · 100990
DOI: 10.1016/j.lanmic.2024.100990 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Lancet Microbe, 2025-02. Verfasst von Felipe Vásquez-Ponce und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, Brazil; One Health Brazilian Resistance P…. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Council for Scientific and Technological Development, Bill & Melinda Gates Foundation, State of Sao Paulo Research Foundation.
Abstract (Originalsprache)
WHO recently updated the list of bacterial priority pathogens, categorising carbapenem-resistant Klebsiella pneumoniae (CRKP) among the critical group.1 In this regard, the endemic status of CRKP has been associated with the widespread dissemination of K pneumoniae carbapenemase-2 (KPC-2),2 with an epidemiological shift because of a considerable annual increase in cases involving New Delhi metallo-β-lactamase (NDM) carbapenemases.3,4 During the COVID-19 pandemic, countries across Latin America and the Caribbean observed a rapid and widespread increase in K pneumoniae co-producing carbapenemases.
Autor:innen und Institutionen
- Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, Brazil; One Health Brazilian Resistance Project (OneBR), São Paulo, Brazil.
- Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, Brazil; Hospital de Guarnição de Natal, Rio Grande do Norte, Brazil.
- Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, Brazil; One Health Brazilian Resistance Project (OneBR), São Paulo, Brazil; Antimicrobial Resistance Institute…
- One Health Brazilian Resistance Project (OneBR), São Paulo, Brazil; Department of Clinical Analysis, School of Pharmacy, University of São Paulo, São Paulo, Brazil.
- Hospital de Guarnição de Natal, Rio Grande do Norte, Brazil.
Förderung
- National Council for Scientific and Technological Development
- Bill & Melinda Gates Foundation
- State of Sao Paulo Research Foundation
Zitieren
APA
Vásquez-Ponce, F., Vianello, M., Becerra, J., Pariona, J. G. M., Dantas, K., Melocco, G., Oliveira, G. M., Esposito, F., & Lincopan, N. (2025). Global epidemiological trend of Klebsiella pneumoniae ST340: emergence of subclade KL15 co-producing K pneumoniae carbapenemase-2 and New Delhi metallo-β-lactamase-7 in the Americas. The Lancet Microbe, 6(2), 100990. https://doi.org/10.1016/j.lanmic.2024.100990
Vancouver
Vásquez-Ponce F, Vianello M, Becerra J, Pariona JGM, Dantas K, Melocco G, et al. Global epidemiological trend of Klebsiella pneumoniae ST340: emergence of subclade KL15 co-producing K pneumoniae carbapenemase-2 and New Delhi metallo-β-lactamase-7 in the Americas. The Lancet Microbe. 2025;6(2):100990. doi:10.1016/j.lanmic.2024.100990
BibTeX
@article{VsquezPonce2025,
author = {Vásquez-Ponce, Felipe and Vianello, Marco and Becerra, Johana and Pariona, Jesus G M and Dantas, Karine and Melocco, Gregory and Oliveira, Guilherme M and Esposito, Fernanda and Lincopan, Nilton},
title = {Global epidemiological trend of Klebsiella pneumoniae ST340: emergence of subclade KL15 co-producing K pneumoniae carbapenemase-2 and New Delhi metallo-β-lactamase-7 in the Americas},
journal = {The Lancet Microbe},
year = {2025},
volume = {6},
number = {2},
pages = {100990},
doi = {10.1016/j.lanmic.2024.100990}
}
EUVIMED